Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Kotwal SS, Perkovic V
In addition to their use in diabetes care, select branded versions, such as Wegovy (semaglutide) and Zepbound (tirzepatide), have received separate FDA approval for chronic weight management
Source: Polaris Market Research Analysis GLP-1 Analogues Market Key Players and Competitive Insights Leading market players are investing heavily in research and development to expand their product lines, which will boost the GLP-1 analogues market growth during the forecast period
Tirzepatide is approved at up to 15 mg weekly (Mounjaro/Zepbound)
GHK-Cu plus Argireline: Combines GHK-Cu's structural signaling with Argireline's studies on expression lines
US$ 20.74
)
US$ 26.34
US$ 22.52
